Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
?
Drug:  recombinant thymosin
Find trials that include:  Any drugs shown
Trial Status:  Closed
Results 1-16 of 16 for your search:
Start Over
Phase III Randomized Trial of Thymosin-Alpha-1 Following Radiotherapy for Limited, Nonresectable non-Small Cell Carcinoma of the Lung
Phase: Phase III
Type: Treatment
Status: Completed
Age: 18 to 74
Sponsor: NCI
Protocol IDs: RTOG-8321, RTOG-83-21
Phase III Sequential CMC (CTX/MTX/CCNU) and VAP (VCR/ADR/PCB) with/without Radiotherapy in Limited, Inoperable Small Cell Lung Carcinoma (Summary last modified 06/97)
Phase: Phase III
Type: Treatment
Status: Completed
Age: no age specified
Sponsor: NCI
Protocol IDs: NCI-78-C-19A, NCI-NMOB-813, NCI-T83-1461N, T83-1461
Phase III Chemotherapy with CTX/ADR/VCR/ARA-C/PRED with or without Thymosin for Chronic Lymphocytic Leukemia
Phase: Phase III
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7971, NCI-V84-0020
A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma
Phase: Phase II
Type: Treatment
Status: Completed
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: Ta1-HCC-2K1001, NCT00082082
Chemotherapy with FACP (Ftorafur/ADR/CTX/CACP) with or without Immunotherapy with Thymosin for non-Oat Cell Carcinoma of the Lung
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7653A
Chemotherapy with FACP (Ftorafur/ADR/CTX/CACP) with or without Thymosin or Intravenous Hyperalimentation for Lung Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7751
Chemotherapy with FACP (FT/ADR/CTX/CACP) with and without Thymosin Immunotherapy for Metastatic Squamous Cell Lung Carcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7752
VAP (DAVA/ADR/CACP) Chemotherapy with/without Thymosin for Metastatic Disseminated non-Oat Cell Lung Carcinoma
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7902
Adjuvant Chemotherapy and Immunotherapy with DTIC, Thymosin and BCG for Patients with Surgically Cured Recurrent Melanoma
Phase: No phase specified
Type: Treatment
Status: Completed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7561
CTX/ADR/VCR Induction with Added CCNU/MTX/PCB or CTX/VCR plus Radiotherapy Consolidation for Small Cell Lung Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MSKCC-7891
Phase II Immunotherapy with Thymosin Fraction 5 as a Single Agent in Nonresectable Metastatic or Recurrent Prostatic Carcinoma and Metastatic Renal Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: NCOG-4P821, NCOG-4P-82-1
Adjuvant Thymosin/TAA Immunotherapy, Radiotherapy, plus MTX Chemotherapy for Stage II Regional Epidermoid Lung Cancer
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: PCCC-PU-7612
Chemotherapy with ADR/CACP/Ftorafur plus Immunotherapy with Thymosin for Metastatic Adenocarcinoma and Large Cell Carcinoma of the Lung
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7653
CACP or CACP/BLEO/MTX with or without Thymosin Immunotherapy for Advanced Head and Neck Cancer and Genitourinary Tumors
Phase: No phase specified
Type: Treatment
Status: Closed
Age: no age specified
Sponsor:
Protocol IDs: MDA-DT-7664
Start Over